TSXV: MNOW OTCQB:MDNWF

1Canada’s On-Demand Virtual Pharmacy

Investor Presentation Q3 2021

TSXV: MNOW

OTCQB: MDNWF

Canada’s On-Demand Pharmacy


GeneralUnless otherwise indicated or the context otherwise requires, all references in this presentation to “Mednow”, “Mednow.ca”, the “Company,” “we,” “our,” “ours,” “us” or similar terms refer to Mednow Inc., together with its subsidiaries. All references to “$”, “C$”, “dollars” are to Canadian dollars. All references to “US$” are to United States dollars. Capitalized terms used herein that are not otherwise defined have the meanings ascribed to such terms in the final long form prospectus of Mednow dated February 26, 2021 (the “Prospectus”) available on SEDAR under Mednow’s profile at www.sedar.com.

Any graphs, tables or other information demonstrating our historical performance or that of any other entity contained in this presentation are intended only to illustrate past performance and are not necessarily indicative of our or such entities’ future performance. The information contained in this presentation is accurate only as of the date of this presentation or the date indicated. No securities regulatory authority has expressed an opinion about the securities described herein and it is an offence to claim otherwise.

Cautionary Note Regarding Forward-Looking InformationThis presentation contains “forward-looking information” for purposes of applicable Canadian securities laws (“forward-looking statements”). Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current beliefs, expectations or

assumptions regarding the future of our business, future plans and strategies, our operational results and other future conditions. Forward-looking statements can be identified by words such as “anticipate”, “believe”, “estimate”, “expect”, “intend”, “may”, “plan”, “predict”, “project”, “seek”,“target”, “potential”, “will”, “would”, “could”, “should”, “continue”, “contemplate” and other similar expressions, although not all forward-looking statements contain these identifying words. These forward-looking statements include all matters that are not historical facts, and include statementsregarding our intentions, beliefs or current expectations concerning, among other things, our operational performance, market opportunities, estimates relating to market growth, the intention to grow the business operations and expand into additional jurisdictions, planned activities of theCompany, future outlook and goals, prospects, strategies and the industry in which we operate. Forward-looking statements are based on our current expectations, beliefs, assumptions, estimates and forecasts about the Company’s business and the industry and markets in which it operates,including among others, assumptions relating to: (i) the ability of the Company to successfully expand into additional jurisdictions; (ii) that the telemedicine and pharmacy market will grow at the rate expected; (iii) the availability of financing; (iv) that third party contractors and supplies andregulatory approvals required to conduct the Company’s planned activities will be available on reasonable terms and in a timely manner; and (v) that general business, legislative and economic conditions will not change in a material adverse manner. Despite a careful process to prepare and reviewthe forward-looking statements, there can be no assurance that the underlying opinions, estimates, and assumptions will prove to be correct.

By their nature, forward-looking statements involve known and unknown risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those that are disclosed in or implied by such forward-looking statements. These risks and uncertaintiesinclude, but are not limited to, the failure of the Company to realize the benefits of its expansion plans as expected; the inability of the Company to obtain the capital or approvals, permits or licenses required to achieve its business objectives; unanticipated costs; reliance on key management andother personnel; potential downturns in economic conditions; increased competition; changes in laws and regulations; other risks associated with the Company’s industry; and those described in greater detail under “Risk Factors” in the Prospectus. If any of these risks materialize, or if any of theabove assumptions underlying forward-looking statements prove incorrect, actual results and developments may differ materially from those made in or suggested by the forward-looking statements contained in this presentation. Given these risks and uncertainties, you are cautioned not to placeundue reliance on these forward-looking statements. Any forward-looking statement that we make in this presentation speaks only as of the date of this presentation, and, except as required by law, we undertake no obligation to update any forward-looking statements or to publicly announce theresults of any revisions to any of those statements to reflect future events or developments. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless specifically expressed as such, and should only be viewed ashistorical data.

Trademarks

This presentation includes certain trademarks, which are protected under applicable intellectual property laws and are the property of Mednow. Solely for convenience, our trademarks referred to in this presentation may appear without the ® or ™ symbol, but such references are not intended to

indicate, in any way, that we will not assert our rights to these trademarks to the fullest extent under applicable law. All other trademarks used in this presentation are the property of their respective owners.

Cautionary Note Regarding United States Securities Laws

This presentation does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities of Mednow in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such

jurisdiction. The securities of Mednow have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, "U.S.

persons," as such term is defined in Regulation S under the U.S. Securities Act, unless an exemption from such registration is available.

IN MAKING AN INVESTMENT DECISION, INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE COMPANY, INCLUDING THE MERITS AND RISKS INVOLVED. THE SECURITIES OF THE COMPANY HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION OR BY ANY STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY, NOR HAVE ANY OF THE FOREGOING AUTHORITIES PASSED ON THE ACCURACY OR ADEQUACY OF THIS PRESENTATION. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

Readers should be aware that the acquisition, holding or disposition of the securities of Mednow may have tax consequences both in Canada and the United States. The tax consequences of the acquisition, holding or disposition of such securities for investors who are resident in, or citizens of, the United States are not described herein. Consequently, any prospective investor is advised to consult their own tax advisors regarding the application of federal income tax laws to their particular circumstances, as well as any state, provincial, local, foreign and other tax consequences of investing in the securities of Mednow and acquiring, holding or disposing of such securities. Investing in the securities of Mednow involves risks. An investment in the securities is suitable only for investors who fully understand, and are capable of bearing, the risks of such investment. Prospective investors should review and consider carefully the information available on Mednow’s profile at www.sedar.com, including the “Risk Factors” described in the Prospectus.

Notice and Disclaimer

http://www.sedar.com/

http://www.sedar.com/


Proven managementCo-Founders have proven experience ranging from brick-and-mortar pharmacy consolidation to global pharmaceutical distribution and the delivery of healthcare through technology

A virtual and diverse healthcare offeringAnchored in pharmacy, Mednow delivers a digital-first healthcare services platform, with unique pharmacy offerings and adjacent healthcare services such as telemedicine and mental health support

Large and untapped market of over $47 Billion1

Pharmacy market ripe for a digital disruption, telemedicine growing at 64%2 annualized as health consumers go virtual

Investment Highlights

1. IBISWorld, Pharmacies & Drug Stores in Canada, 2020

2. Frost & Sullivan, Telehealth to Experience Massive Growth with COVID-19 Pandemic […], 2020


Healthcare is a Large Consumer Market

HEALTHCARE2

$264B

Restaurants1

$21B


Transportation1

$71B

Accomodation1

$8B

Education1

$106B

1. https://www150.statcan.gc.ca/ 2. CIHI National Health Expenditure, 2019

Technology has displaced incumbents in many consumer industries - Mednow seeks to do the same in Healthcare


Digital Pharmacy Industry in Early Days

$47 Billion Pharmacy Market 3

$264 BillionHealthcare Market 2$2 Billion

TelemedicineMarket 4

1. National Association of Boards of Pharmacies.

2. CIHI National Health Expenditure, 2019

3. IBISWorld, Pharmacies & Drug Stores in Canada, 20204. Fortune Business Insights, Telehealth Market Size, Share & COVID-19 Impact Analysis […], 2020; Canadian figures estimated from North American market

Over 99% of the over 10,000 pharmacies in Canadaare the traditional brick and mortar model, focused on local business 1


2/3of Canadians over the age of

65 take more than threemedications a day 2

1. Canadian Pharmacists Association, 20202. Canadian Institute for Health Information, Drug Use Among Seniors, 2016

Community pharmacists are seen up to 10x more than family

physicians 1

of Canadians with chronic illness do not take medications as prescribed 2

50%

Mednow Improves Access to a Commonly Needed Healthcare Provider: The Pharmacist


Creating a Unique Ecosystem Focused on Value to Patients

Mednow is building a better digital pharmacy

Channel integration via national pharmacy and

virtual care

Rapid delivery to elevate patient experience


Building a Holistic Care Offering

Drug Adherence SolutionsMental Health Support

Patient books doctor through the app

Patient meets doctor virtually

Script filled and delivered by Mednow

1 2 3

Diagnosis to Delivery


Our Business Model: virtual pharmacy platform is our foundation for a loyal consumer

Prescriptions Subscriptions & Recurring Telehealth Products and services

Mednow is anchored in pharmacy

Pharmacy driven services to assist adherence, PillSmart

Integrated virtual health offering

Over-the-counter products, Karie dispenser, mental health

support

Dispensing feesMark-up on medication

Subscription fees and returning customers enhance lifetime value (LTV)

Fee for service per visitDirect referrals to pharmacy

Sale of curated and unique, products and services

HolisticOffering

Business Model

Mednow’s Revenue ModelTraditional pharmacy revenue model + innovative virtual platform to drive long-term patient relationships

1. This list reflects Mednow’s target revenue generating drivers. There is no guarantee that the company will be successful in implementing and/or maintaining each of these drivers.

2. Source: Canadian Institute for Health Information3. Approximate values based on Mednow East and West fulfillment centre financial statements, between November 1, 2020 and April 30, 2021.

Revenue drivers 1

• Mark-up on medications

• Dispensing fees

• Non-dispensing services

• Sale of non-prescription pharmacy products

• Physician services revenue


$916Avg. prescription spend per year 2

$1,072Avg. total spend

per year 2

30%Gross

margins 3


National Coverage Opens Vast Institutional Market

Brokers / Advisors

Industry Associations

Manufacturer Services

The value proposition for business clients (employers, group insurance providers, brokers and associations): 1

• Decreased costs of prescription medication for clients, the largest medical benefit program expense

• Improved health of employees

• Increased adoption of virtual services

Institutional business model is attractive due to:

• Scaled client acquisition

• Lowered cost of patient acquisition for Mednow

Recent Win: On May 17, 2021, Mednow became the Preferred Pharmacy Provider of the PolicePensioners Association of Ontario, with 12,000 members

Marketing Partnerships

1. These value propositions reflect the Company’s expectations; however, there is no guarantee that they will be achieved or maintained.


Operational Fulfillment Centres

Targeted Fulfillment Centres3

Fulfillment Centres in Development2

1. Mednow’a targeted objective.2. Subject to successful pharmacy applications.3. The development and operation of these fulfillment centers is subject to

successful receipt of pharmacy licenses in each of the designated provinces.

Mednow Plans to Scale NationallyCurrent fulfillment centres can service all of BC and Ontario, 19 million+ Canadians


Advanced adherence support systems

Pharmacy of the Future: combining tech with unique adherence solutions for better patient outcomes

Mednow’s PillSmartTM system improves medication adherence by organizing medications in easy-to-use pouches marked by date and time at no additional cost to customers

The Karie system integrates with PillSmartTM to provide an automatic medication dispenser that schedules, reminds and delivers medication with the touch of a button


Acquisition of Medvisit: expanded offering for those with limitations on mobility

30,000Patient home visits

per year

400,000Patients in Medvisit

database

1. Canadian Mental Health Association (CMHA) in partnership with UBC researchers, 2020.

Transaction highlights

• In August 2021, Mednow closed the acquisition of Medvisit, Canada’s largest and longest standing doctor home visit provider

• In operation for 30 years, network of 100 doctors treating acute and episodic illness and injury, primarily in the GTA

• Purchased for $1.3 million in cash, with earn-out of $680,000 subject to profitability milestones

• In latest fiscal year, Medvisit earned revenue of approximately $3 million and a gross margin of 25%


Aligning with a Key Need: mental health support

75%Of medical patients

present mental health issues1

$6 billionSpent by insurers on

mental health in 20191

1. Canadian Mental Health Association (CMHA) in partnership with UBC researchers, 2020.

Transaction highlights

• Mednow invested $500,000 for an equity interest of 9% in Life Support Mental Health Inc. (“LSMH”)

• LSMH is a medical technology company providing mental health support to patients through an assessment tool administered by a health professional

• Mednow benefits from not only the growth of LSMH, but this revenue generating concept can be incorporated into the Mednow business model

• Mednow pharmacists and physicians can assist in the diagnosis and treatment of mental health conditions, and earn a fee for the assessment

$6.5M Raised inSeries A Round

June 2020

Established ON and BC Fulfillment Centers1

September 2020Web App

Released

Nov. / Dec. 2020

Key Milestones: accelerated development to service rapid adoption of digital healthcare in Canada


1. Mednow East Inc. and Mednow Pharmacy Inc. are fulfillment partners2. Mednow’a targeted objective.

Q1 2021

Fully capitalize the company and IPO

Q2 2021

Announced Nova Scotia and Manitoba fufillment centres

Q3 20212

National pharmacy footprint

Q4 20212

Establish institutional clients


Digital Healthcare and Pharmacy is Attracting Capital

The information presented above is comprised of "comparables", which is information that compares Mednow to other issuers. The other issuers in the comparables were included on the basis that they are telemedicine, virtual pharmacy or healthcare companies and are considered to be an appropriate basis for comparison to Mednow because they operate in the same or a similar industry to Mednow. Information about the other issuers in the comparables was obtained from public sources and has not been independently verified by Mednow. There are many risks associated with relying upon the comparables to make an investment decision, including the risk that the performance of Mednow will not necessarily meet or exceed those of the comparable issuers and there is no guarantee that an investor will achieve a return on investment similar to those issuers. If the information concerning the comparables contains a misrepresentation, an investor in Mednow will not have a remedy under securities legislation.

Amazon acquired

PillPack for

US$750M+

PillPack is an online pharmacy

that uses technology to

manage medication and coordinate

refills, while delivering prescriptions

on a monthly basis

Raised US$300M

at a US$1B valuation

in April 2021

Capsule is a digital pharmacy

offering virtual healthcare and

delivery in six U.S. cities

Latest financing reportedly

with a valuation

over $1B

Alto is a digital pharmacy offering

virtual pharmacy services and delivery

in 11 U.S. cities and metropolitan areas

Raised US$500M

at a US$5B valuation

in March 2021

Ro connects telehealth, diagnostics,

and pharmacy services to provide high-

quality, affordable healthcare without

the need for insurance


Executives and FoundersKarim Nassar, CEO & Co-Founder• Computer engineer with 15 years of experience in pharmacy,

technology, and healthcare logistics

• Built and managed Air Liquide’s (EPA: AL) Western Canada home oxygen logistics network after assuming various roles in finance, M&A, strategy, and marketing in France and Canada

• Led retail & specialty pharmacy strategy initiatives at McKesson (NYSE: MCK) and Innomar Strategies, a subsidiary of AmerisourceBergen (NYSE: ABC)

• Vice President of Digital Strategy at the Care Group of Pharmacies

• Karim holds a Bachelor’s of Applied Science from the University of Toronto and an MBA from Queen’s University

• Ali holds a Bachelor of Science degree in Pharmacy from the University of Toronto and has over 20 years of experience in pharmacies, business development, and operations

• CEO and Co-Founder of the Care Group of Pharmacies, the largest pharmacist controlled independent pharmacy chain in Canada with over 45 locations and $150M of revenue

• Recently completed a $30M growth investment by Crédit MutuelEquity, a €3B private equity fund of Crédit Mutuel Alliance Fédérale

• Named one of Canada’s Top 40 Under 40 for 2020, presented by BNN Bloomberg and the Financial Post

Ali Reyhany, Director & Co-Founder Felipe Campusano, Director & Co-Founder

• Holds a Pharmacy degree from the University of Toronto and a Bachelor’s of Science degree from Queen’s University

• Purchased first pharmacy the day he graduated pharmacy school

• Has amassed a pharmacy network of over 50 pharmacies and healthcare services

• Founder and Chair of Liver Care Canada, a network of specialty liver disease treatment clinics

Ben Ferdinand, CFO• Master of Business Administration (MBA) from Ivey Business School at the

University of Western Ontario and was awarded the CPA, CMA designation and holds the ICD.D designation from the Institute of Corporate Directors

• Previously served as Chief Financial Officer to a publicly traded medical health and wellness company (acquisitions of over $300 million, with over $70 million in capital raised)

• Has served on the boards of CanDeal Inc., a provider of electronic debt trading services (co-owned by Canada’s six major bank-owned dealers and TMX) and Shorcan Brokers Ltd., an inter-dealer debt broker.


Advisors and Independent Directors

Dr. Karim Vellani, Medical Director

Family physician at St. Michael’s Hospital

Founder and Medical Director of MediCall

Lecturer at the University of Toronto

Chris Fischer, Medical Managing Partner

Previously Director of Operations for the University of Ottawa

Health Services Director of the Ontario University and College Health Association

since 2006

Ghassan Halazon, eCommerce Advisor

Founder and CEO of EMERGE Commerce (TSXV: ECOM)

Canada’s Top 40 under 40 honourees for 2020, presented

by BNN Bloomberg and National Post

Sameer Lalji, Chief TechnologyOfficer

Previously Chief Product Officer at VerticalScope

Previously CTO at DealTap, Managing Director for Majid Al Futtaim

in the United Arab Emirates, and Advisor for Quantum Mob and

Band of Coders

Kia Besharat, Director

Senior Managing Director at Gravitas Securities

Director of EMERGE Commerce (TSXV: ECOM)

Investment Industry Association of Canada (IIAC)

as a Top 40 Under 40 Award Nominee in 2018

Mahdi Shams, Director

Partner at MLT Aikins LLP

Advises clients on corporate governance, continuous disclosure obligations,

director and officer duties and obligations and general corporate law

matters


What Our Satisfied Customers Are Saying

Really amazed at the level of service I received.

Doesn’t get much better than this!

—Alan

First time using Mednow and order came right away.

This company is amazing!

—Ziba

Mednow has been very professional and

quick delivering the medicines

I needed. This was very helpful for me,

especially during the pandemic.

– Suneesh


Mednow in the News

Mednow.ca was designed with the best patient experience in mind, it sets a new standard for quality care paired with virtual access to all pharmacy services

An online pharmacy and virtual health provider looking to improve Canadian’s Health using technology and home delivery

All-Encompassing Virtual Platform Aims to Disrupt Canada’s Pharmacy Industry

Mednow.ca’s deep industry knowledge coupled with a growing demand for virtual care and pharmacy delivery makes it a very attractive opportunity in the Canadian investment landscape

Mednow is essentially a virtual pharmacy, offering patients access to pharmacy services via a web-based app or website

22Canada’s On-Demand Virtual Pharmacy 22

Thank YouContact us:

[email protected]

www.investors.mednow.ca

1-855-686-6300

www.mednow.ca

TSXV: MNOW OTCQB:MDNWF

Documents

Transcript of TSXV: MNOW OTCQB:MDNWF